NCT00284908View on ClinicalTrials.gov

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
EsophagitisGastroesophageal RefluxStomach UlcerDuodenal Ulcer
Interventions
DRUG

S-Tenatoprazole-Na (STU-Na)

30 mg, 60 mg, 90 mg and 120 mg of STU-Na for 5 days every morning

Trial Locations (1)

78229

Healthcare Discoveries, Inc., San Antonio

All Listed Sponsors
collaborator

STEBA LABORATORIES LTD.

UNKNOWN

lead

STEBA France

INDUSTRY

NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers | Biotech Hunter | Biotech Hunter